Purchases and Sales Made in Q4 2020 in Trillium Therapeutics Inc. (TRIL)
This table provides information about the institutional ownership of Trillium Therapeutics Inc. (TRIL) during Q4 2020. The information is specifically focused on institutions that hold shares of Trillium Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 16, 2021
Q4 2020
|
Exodus Point Capital Management, LP
New York, NY |
BUY
|
- |
25.5K+ 82.72% |
N/A
|
56.3K
$0
|
|
|
Feb 12, 2021
Q4 2020
|
Legal & General Group PLC
London, X0 |
BUY
|
- |
2.61KNew |
N/A
|
2.61K
$0
|
|
|
Aug 30, 2024
Q4 2020
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
BUY
|
- |
1K+ 5.76% |
N/A
|
18.4K
$0
|
|
|
Jan 10, 2025
Q4 2020
|
Nomura Asset Management CO LTD
Tokyo, M0 |
BUY
|
- |
0New |
N/A
|
0
$0
|
|
|
Mar 11, 2022
Q4 2020
|
Alpha Centric Advisors LLC
San Juan, PR |
SELL
|
- |
-500Closed |
N/A
|
0
$0
|